New ETF Book by Larry Connors - Click here to read more
Summary of Events
Event Date and Time (IST) Medium
Release of financial results October 23, after the Board Meeting Email, Media, Company website, Businesswire
Earnings Call October 23, 6.00 PM IST / 8.30 AM EST Hosted by the Company
(Details below)
Webcast of Earnings Call October 23, 6.00 PM IST / 8.30 AM EST through October 27, 2009 URL available on Company's website,
www.drreddys.com
Transcripts of the Earnings call Will be available on the Company's website URL available on Company's website, www.drreddys.com
Earnings Call
Following the release, the management of the Company will host an earnings call to discuss the Company's financial performance.
Conference Dial-In Numbers
Primary Number: +91 22 4039 2525
Secondary Number: +91 22 6629 0101
The numbers listed above are universally accessible from all
networks and all countries.
Local Access Number: * 60001221
Available in - Delhi, Chennai, Hyderabad, Bangalore, Kolkata
* The Local Access Number is accessible from all major carriers
except BSNL/MTNL
International Toll Free Number: USA: 1 866 746 2133
UK: 0 808 101 1573
Singapore: 800 101 2045
Hong Kong: 800 964 448
No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.
Audio Webcast
The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through October 27, 2009. For play back dial in phone No: 022 3065 1212 and ID: 375#.
Transcript
The transcript of the earnings call will also be available on the Company's website.
About Dr Reddy's
Established in 1984, Dr. Reddy's Laboratories (NYSE: RDY | Quote | Chart | News | PowerRating) is an emerging global pharmaceutical company with proven basic research capabilities. The company develops, manufactures and markets a wide range of pharmaceutical products in India and overseas. Dr. Reddy's produces finished dosage forms, active pharmaceutical ingredients, diagnostic kits, critical care and biotechnology products. The basic research program of Dr. Reddy's focuses on cancer, diabetes, bacterial infections and pain management. Website: http://www.drreddys.com.
SOURCE: Dr. Reddy's Laboratories
For Dr. Reddy's Laboratories Investor Relations: Kedar Upadhye, +91-40-66834297 kedaru@drreddys.com or Raghavender R, +91-40-66511529 raghavenderr@drreddys.com or Milan Kalawadia (North America), 908-203-4931 mkalawadia@drreddys.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.